ARVN 240816 35.00C (ARVN240816C35000) Stock Options, News & Quotes

0.70
-1.35-65.85%

15min DelayClose Jul 22 15:59 ET

0.75High0.70Low

SymbolStock Name

Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

Comments

Moomoo AI

Feb 26 13:36

Arvinas' high P/S ratio could be worrisome as revenue forecasts are not promising. The anticipated future revenues may not sustain the current positive sentiment. Without significant improvements, these prices may not be deemed reasonable.

Revenues Not Telling The Story For Arvinas, Inc. (NASDAQ:ARVN) After Shares Rise 28%

Moomoo AI

Feb 20 15:08

Sean Cassidy expressed confidence in the company's future and the promising clinical development and commercial opportunity for the PROTAC(R) protein degrader pipeline. The company's leadership acknowledged Cassidy's pivotal role in creating Arvinas' strong financial profile.

Press Release: Arvinas Announces Chief Financial Officer Transition

Stoic Trader

Feb 7 00:21

$Arvinas(ARVN.US)$ 👀 new hoy

JP88

Dec 8, 2023 17:35

$Arvinas(ARVN.US)$ I hope everyone bought that sub 14 dip! This thing has been a beast.

Analysts Notebook

Jun 21, 2022 06:06

ColumnsTop upgrades and downgrades on 6/21: XOM, ADBE, UAA, BEKE and more

Upgrades
• $ABM Industries(ABM.US)$ : Baird Upgrades to Outperform from Neutral - PT $50
• $American Tower Corp(AMT.US)$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $Church & Dwight(CHD.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $Chewy(CHWY.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $Centene(CNC.US)$ : Credit Suisse Upgrades to Outperform from...